Related references
Note: Only part of the references are listed.Use of HIV Post-Exposure Prophylaxis Among Men Who Have Sex With Men in Shenzhen, China: A Serial Cross-Sectional Study
Yao Wang et al.
AIDS AND BEHAVIOR (2022)
HIV-1 integrase strand transfer inhibitors: a review of current drugs, recent advances and drug resistance
Nokuzola Mbhele et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2021)
Prevalence of integrase strand transfer inhibitor (INSTIs) resistance mutations in Henan Province, China (2018-2020)
Zhaojie Yang et al.
INFECTION (2021)
Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance
Philip L. Tzou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Long-acting injectable cabotegravir for the prevention of HIV infection
Meredith E. Clement et al.
CURRENT OPINION IN HIV AND AIDS (2020)
The effect of 90-90-90 on HIV-1 incidence and mortality in eSwatini: a mathematical modelling study
Adam Akullian et al.
LANCET HIV (2020)
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults 2020 Recommendations of the International Antiviral Society-USA Panel
Michael S. Saag et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Absence of Integrase Inhibitor-Associated Resistance Among Antiretroviral Therapy-Naive HIV-1-Infected Adults in Guangdong Province, China, in 2018
Yun Lan et al.
INFECTION AND DRUG RESISTANCE (2020)
High predictive efficacy of integrase strand transfer inhibitors in perinatally HIV-1-infected African children in therapeutic failure of first- and second-line antiretroviral drug regimens recommended by the WHO
Ralph-Sydney Mboumba Bouassa et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Lack of HIV-1 integrase inhibitor resistance among 392 antiretroviral-naive individuals in a tertiary care hospital in Beijing, China
Lifeng Liu et al.
AIDS (2019)
Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants
Steven J. Smith et al.
RETROVIROLOGY (2018)
Resistance to HIV Integrase Inhibitors: About R263K and E157Q Mutations
Charlotte Charpentier et al.
VIRUSES-BASEL (2018)